M.K. Bharty et al. / Journal of Molecular Structure 1011 (2012) 34–41
41
the a axis provides a supramolecular network by means of various
types of H-bonds (Fig. 7). The two 2-mpotꢁ ligands are covalently
bonded to nickel in a distorted octahedral geometry with axial bond
angles of 90.73(6) and 92.92(6)° but equatorial bond angles of
82.95(8) and 82.74(7)°, respectively in units containing Ni(1) and
Ni(2). The two 2-mpot anions occupy the trans positions, bonded
through oxadiazole nitrogens at the distances of 2.111 Å Ni(1)
and 2.153 Å Ni(2). The four equatorial sites in complex 3 are occu-
pied by the two bidentate N,N0-ethylenediamine co-ligands. The
bond length for Ni(1)AN(3A) (Noxa) is shorter than the correspond-
ing bond length in Ni(2), showing stronger bonds in Ni(1) as com-
pared to Ni(2). The two NiAN(en) distances in both the units are
different. The Ni(1)AN(1A) bond length is longer than Ni(2)AN(1B)
while Ni(1)AN(2A) is shorter than Ni(2)AN(2B). The binding of
nickel with en involves the formation of two five membered chelate
rings with bite angles of 82.95(8)° and 82.74(7)° in Ni(1) and Ni(2),
respectively, again showing a slight distortion from an ideal octahe-
dral geometry. Weak intermolecular NAHꢀ ꢀ ꢀS interactions (Table 5)
between thione sulfur of oxadiazole and CH2 and NH2 hydrogens of
en stabilize the crystal structure of 3 (Fig. 8). In addition, there are
intramolecular CAHꢀ ꢀ ꢀN interactions between hydrogen of phenyl
ring and nitrogen atoms of oxadiazole ring which lead to the forma-
tion of a supramolecular architecture (Fig. 8).
or e-mail: deposit@ccdc.cam.ac.uk. Supplementary data associated
with this article can be found, in the online version, at doi:10.1016/
References
[1] B.J. McCormick, R. Bereman, D.M. Baird, Coord. Chem. Rev. 54 (1984)
99–130.
[2] R.P. Burns, F.P. McCullough, C.A. McAuliffe, Adv. Inorg. Radiochem. 23 (1980)
211–280.
[3] T.N. Lockyer, R.L. Martin, Prog. Inorg. Chem. 27 (1980) 223–324.
[4] R. Beckett, B.F. Hoskins, Chem. Commun. (1967) 909–910.
[5] R. Beckett, B.F. Hoskins, J. Chem. Soc., Dalton Trans. (1974) 622–625.
[6] P. Tripathi, A. Pal, V. Jancik, A.K. Pandey, J. Singh, N.K. Singh, Polyhedron 26
(2007) 2597–2602.
[7] V. Jakubkiene, M.M. Burbuliene, G. Mekuskiene, E. Udrenaite, P. Gaidelis, P.
Vainilavicius, IL Farmaco 58 (2003) 323–328.
[8] M.M. Dutta, B.N. Goswami, J.C.S. Kataky, J. Heterocyclic Chem. 23 (1986) 793–
795.
[9] M. Du, X.-J. Zhao, J. Mol. Struct. 694 (2004) 235–240.
[10] I. Mir, M.T. Siddiqui, A.M. Comrie, J. Chem. Soc. 16 (1971) 2798–2799.
[11] A. Omar, M.E. Mohsen, O.M. Aboulwafa, J. Heterocyclic Chem. 21 (1984) 1415–
1418.
[12] G.L. Hassert, J.W. Poutsiava, D. Papadrianos, J.C. Burke, B.V. Carver, Toxicol.
Appl. Pharmacol. 3 (1961) 726–741.
[13] O.H. Amin, L.J. Al-Hayaly, S.A. Al-Jibori, T.A.K. Al-Allaf, Polyhedron 23 (2004)
2013–2020.
[14] H.X. Xu, J.P. Ma, R.Q. Huang, Y.B. Dong, Acta Cryst.
m2462–2463.
E 61 (2005)
[15] Y.T. Wang, G.M. Tang, Inorg. Chem. Commun. 10 (2007) 53–56.
[16] M. Du, Z.H. Zhang, X.J. Zhao, Q. Xu, Inorg. Chem. 45 (2006) 5785–5792.
[17] Y.T. Wang, G.M. Tang, W.Y. Ma, W.Z. Wan, Polyhedron 26 (2007)
782–790.
[18] Z.H. Zhang, C.P. Li, Y.L. Tian, Y.M. Guo, Inorg. Chem. Commun. 11 (2008) 326–
329.
[19] Z.H. Zhang, Y.L. Tian, Y.M. Guo, Inorg. Chim. Acta 360 (2007) 2783–2788.
[20] Y.T. Wang, G.M. Tang, Z.W. Qiang, Polyhedron 26 (2007) 4542–4550.
[21] K. Obi, A. Kojima, H. Fukuda, K. Hirai, Bioorg. Med. Chem. Lett. 5 (1995) 2777–
2782.
[22] L. Mishra, M.K. Said, H. Itokawa, K. Takeya, Bioorg. Med. Chem. 3 (1995) 1241–
1245.
[23] K.M. Khan, M. Rasheed, Z. Ullah, S. Hayat, F. Kaukab, M.I. Choudhary, A.
Rahman, S. Perveen, Bioorg. Med. Chem. 11 (2003) 1381–1387.
[24] B.W. Brown, E.C. Lingafelter, Acta Cryst. 16 (1963) 753–758.
[25] Oxford Diffraction, (2007) CrysAlis RED and CrysAlis CCD Versions 1.171.31.8.
Oxford Diffraction Ltd Abingdon, Oxafordshire, England.
[26] G.M. Sheldrick, Acta Cryst. A 64 (2008) 112–122.
[27] I.J. Bruno, J.C. Cole, P.R. Edgington, M. Kessler, C.F. Macrae, P. McCabe, J.
Pearson, R. Taylor, Acta Cryst. Sect. B 58 (2002) 389–397.
[28] L.J.J. Farrugia, Appl. Cryst. 30 (1997) 565.
4. Conclusion
This paper reports on the syntheses and crystal structures of
three new Cd(II) and Ni(II) complexes of 5-(4-methoxy-phenyl)-
1,3,4-oxadiazole-2-thione, 5-(2-pyridyl)-1,3,4-oxadiazole-2-thione
and 5-(2-methoxy-phenyl)-1,3,4-oxadiazole-2-thione containing
ethylenediamine as the coligand. In [Cd(4-mpot)2(en)2] (1), [Ni(2-
pytone)2(en)2] (2) and [Ni(2-mpot)2(en)2] (3) the metal ion has a
six coordinate octahedral arrangement involving 4N atoms of
two en ligands and two covalently bonded N atoms of oxadiaz-
ole-2-thione anions. There are two independent complexes in the
asymmetric unit of complex 3 and in each unit the nickel atom is
on the center of inversion. The crystal structures of the complexes
are stabilized by intermolecular and intramolecular hydrogen
bonding. Complex 1 is also stabilized by weak
occurring between phenyl (Cgph) and 1,3,4-oxadiazole (Cgoxa
rings.
p p interactions
ꢀ ꢀ ꢀ
)
[29] P. Molina, A. Tarraga, A. Espinosa, Synthesis 9 (1988) 690–693.
[30] G.S. Patricia, G.T. Javier, A.M. Miguel, J.A. Francisco, R. Teofilo, Inorg. Chem. 41
(2002) 1345–1347.
[31] A.B.P. Lever, Inorganic Electronic Spectroscopy, second ed., Elsevier,
Amsterdam, 1984.
[32] G. Ma, A. Fischer, R. Nieuwendaal, K. Ramaswamy, S.E. Hayes, Inorg. Chim. Acta
358 (2005) 3165–3173.
Appendix A. Supplementary material
CCDC 840588, 813076 and 813077 contain the supplementary
crystallographic data for [Cd(4-mpot)2(en)2] (1), [Ni(2-pytone)2
(en)2] (2) and [Ni(2-mpot)2(en)2] (3), respectively. These data can
ter, 12 Union Road, Cambridge CB2 IEZ, UK; fax: +44 1223 336 033;
[33] A. Terron, A.G. Rosa, J.J. Fiol, S. Amengual, M.B. Oliver, R.M. Totaro, M.C. Apella,
E. Molins, I. Mata, J. Inorg. Biochem. 98 (2004) 632–638.
[34] P.J. Squattrito, T. Iwamoto, S. Nishikiori, Chem. Commun. 23 (1996) 2665–
2666.
[35] H. Icbudak, H. Olmez, O.Z. Yesilel, F. Arslan, P. Naumov, G. Jovanovski, A.R.
Ibrahim, A. Usman, H.K. Fun, S. Chantrapromma, S.W. Ng, J. Mol. Struct. 657
(2003) 255–270.